title: Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review.
abstract: A 58-year-old woman presented to a tertiary care centre with signs and symptoms of acute cholecystitis, cholelithiasis and diagnoses of a high-grade neuroendocrine tumour of the gallbladder primarily with peritoneal and liver metastases. She had a liver abscess secondary to Salmonella and Enterococcus fecalis that was drained and treated with appropriate antibiotics. Interestingly, the serum chromogranin A levels were within normal limits, but carcinoembryonic antigen was elevated, which helped evaluate responses and pick progression. She was treated with 10 cycles of palliative chemotherapy when malignancy associated complications started to recur, that is, cholangitis, worsening pain, cachexia, intestinal obstruction, etc leading to chemotherapy delays. Her disease progressed during these times with rapid deterioration of performance status. She died of septic complications postlaparotomy for intestinal obstruction. Her progression-free survival remained for 8 months with subjective and objective improvements, and her overall survival remained at 13 months. We describe the course of her illness and give a brief review of the literature.
authors: Department of Oncology, Sultan Qaboos University Hospital, Muscat, Oman.
authors: Muhammad
authors: M
authors: Furrukh
authors: Asim
authors: A
authors: Qureshi
authors: Anna
authors: A
authors: Saparamadu
authors: Shiyam
authors: S
authors: Kumar
mesh_terms: D002272:Carcinoembryonic Antigen / Q000097:blood*; D018278:Carcinoma, Neuroendocrine / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D005704:Gallbladder / Q000473:pathology*; D005706:Gallbladder Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008875:Middle Aged
chemical_list: D002272:Carcinoembryonic Antigen
references: Endocr Relat Cancer. 2004 Mar;11(1):1-18
references: 15027882
references: J Clin Oncol. 2008 Jun 20;26(18):3063-72
references: 18565894
references: J Nucl Med. 2010 Sep;51(9):1349-56
references: 20720050
references: Hepatogastroenterology. 1998 Sep-Oct;45(23):1488-91
references: 9840091
references: Gut. 1993 Sep;34(9):1274-6
references: 8406168
references: Cancer. 2003 Feb 15;97(4):934-59
references: 12569593
references: J Med Assoc Thai. 2000 Jan;83(1):97-102
references: 10710876
references: Digestion. 2000;62 Suppl 1:73-8
references: 10940691
references: Virchows Arch. 1995;425(6):547-60
references: 7697211
references: Cancers (Basel). 2012 Feb 15;4(1):141-55
references: 24213232
references: World J Gastroenterol. 2007 Mar 14;13(10):1608-11
references: 17461457
references: J Clin Gastroenterol. 2010 Nov-Dec;44(10):687-95
references: 20375728
references: J Clin Oncol. 2009 Oct 1;27(28):4656-63
references: 19704057
references: Target Oncol. 2009 Dec;4(4):287-96
references: 19898923
references: J Clin Oncol. 2010 Apr 1;28(10):1652-9
references: 20194865
references: Am J Surg Pathol. 2010 Mar;34(3):300-13
references: 20118772
references: World J Surg. 2005 Jan;29(1):92-101
references: 15599742
references: Hum Pathol. 1986 Jun;17(6):614-20
references: 2872152
references: Acta Chir Scand. 1986 Aug-Sep;152:509-13
references: 3788394
references: J Exp Clin Cancer Res. 2003 Mar;22(1):5-15
references: 12725316
references: Semin Nucl Med. 2010 Mar;40(2):78-88
references: 20113677